-
Patients don’t want to come to the “heart failure”clinic. Let’s focus our efforts on reverse remodeling and
#recovery.#myocardialsubstrate#genetics#noveldrugs https://twitter.com/DrDanielHR/status/1041728524330008576 …
-
VIDEO: What should uro-oncologists know about
#noveldrugs in 2017?@MRoupret,@HopPitieSalpe http://ow.ly/rjvD30e4oYk#oncology@Uroweb -
In 2017, 33% of
#noveldrugs coming to market were#firstinclass. Read more about 2017 FDA approvals in our@Clin_Trials article http://ow.ly/YTSO30j1JyA pic.twitter.com/IyNL1z8cQQ
-
URL: https://bit[.]ly/2HDMErt FDA gave the green light to 59 novel orphan drugs, the most it has approved in nearly two decades.
#OprhanDrugs#RareDiseases#NovelDrugs#PharmaMarket#OrpanDrugDesignation#FDApic.twitter.com/LaGrJSDM5p
-
The early bird registration deadline has been extended..!! Grab the opportunity........!! Register under the early bird to get a discount

#activepharmaceuticalingredient#pharmaceutical#Pharmaceuticalscience#Noveldrugs#Drugdeliverypic.twitter.com/PUIX4HWwze
-
@Bayer looks for#noveldrugs for diseases with high unmet medical need http://ow.ly/AsVX3062dzb#PartnerYourAntibodies Deadline Dec 31, 2016 -
In silico drugs has unveiled a new way discovering novel drugs.
#insilico#noveldrugs https://goo.gl/bNLfdF -
Section Econ Seminar
@WUR 18/6: Itamar Megiddo (@UniStrathclyde): "What is the#value of#antibiotics?#Models of#withholding antibiotics"#NovelAntibiotics#NovelDrugs#HealthTechnologies#valuation#DrugResearch#AntibioticsStewardship#healtheconomicshttps://bit.ly/2KkNsmxPrikaži ovu nit -
Hurry Up......!! Get a discount of $100 on your registration fee by registering under early-bird registration. For Registration visit:https://pharmaconference.bioleagues.com/registration.php/ …
#Pharmaceutics#Biopharmaceutics#Drugdelivery#Drugmanufacture#Noveldrugs#immunomodulators#pharmacovigilancepracticespic.twitter.com/FmzjHW0zOA
-
#Metabolomics can help in finding#potentialnewsites for#therapeuticintervention by identifying#metabolicchanges & can provide information about possible#noveldrugs and#drugscaffolds, indicate interesting#targetsfordrugdevelopment and suggest#bindingpartnersofcompounds. -
Submit the abstarct to the track
#NovelDrugs#DrugDeliverySystems and present your findings in#DrugFormulation at,#Dubai,UAE during December 5-6, 2018
comment below.
Martina Johnson| Program Coordinator
Email id: pharmaceutics@annualmeetings.netpic.twitter.com/6m5NR9kzn7
-
Join us at
#drugdelivery 2019 June 14-15, 2019,#Montreal#Canada PS:https://worlddrugdelivery.wordpress.com/ Contact me: drugdelivery@annualamericacongress.org#Membership#Benefits#B2Bmeetings#Speaker#Delegate#exhibition#sponsors#formulations#excipients#noveldrugs#noveltechnologiespic.twitter.com/NXvjBghpdT
-
immuno-oncology - a new hope for treating
#cancer http://bit.ly/jhcit#immunotherapy#biotech#biopharma#ASCO#noveldrugs -
Compugen Discloses Predictive Structural Biology Infrastructure Platform for Enhanced Discovery of
#NovelDrugs http://ow.ly/nkchb -
URL:https://rarediseases.insightconferences.com/ There were 35
#noveldrugs and biologics approved in 2018 with#orphan_drug_designation. This is the highest number since the passage of the#OrphanDrug Act in 1983. for more@Rarediseasemeet#rarediseases#ultrararediseases#rare#orphandiseases#FDApic.twitter.com/HzVn3Q5Uu8
-
34 of 59 novel drugs (58%) approvals by the FDA in 2018 were approved to treat rare or “orphan” diseases (from the FDA’s Center for Drug Evaluation and Research’s CDER annual report)
#FDA#DrugApprovals#NovelDrugs#OrphanDrug#RareDiseasespic.twitter.com/G0WV6Msy3m
-
#Infectiousdiseases are caused by microorganisms such as#bacteria,#viruses, and#fungi Its market expected to expand at 6.6% CAGR over the forecast period (2014-2025) driven by the need for#noveldrugs to fight#chronicdiseases. Read More @ https://goo.gl/kyhXWt#healthcarepic.twitter.com/Mkb6BahMM3
-
Promising new combination therapy for HDV hepatitis.
Lonafarnib is a prenylation inhibitor. #GItwitter#FOAMed#NovelDrugs https://twitter.com/gbaffy/status/1194244381299138565 …
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.